Skip to main content

COVID-19 N-Protein Human IgA ELISA Kit is a Semi-quantitative ELISA kit for the measurement of COVID-19 N-Protein Human IgA in Plasma, Serum samples.

Be the first to review this product! Submit a review

Publications

Key facts

Detection method
Colorimetric
Sample types
Plasma, Serum
Assay type
Semi-quantitative

Reactivity data

Application
ELISA
Reactivity
Reacts
Dilution info
-
Notes

-

What's included?

1 x 96 Tests
Components
20X Wash Buffer
1 x 25 mL
5X Assay Diluent B
1 x 15 mL
HRP-anti IgA antibody
1 x 1 Vial
Negative Control
1 x 1 Vial
Positive Control
1 x 1 Vial
SARS-CoV-2 N protein coated Microplate
1 x 1 Unit
Stop Solution
1 x 8 mL
TMB One-Step Substrate Reagent
1 x 12 mL

Recommended products

COVID-19 N-Protein Human IgA ELISA Kit is a Semi-quantitative ELISA kit for the measurement of COVID-19 N-Protein Human IgA in Plasma, Serum samples.

Key facts

Detection method
Colorimetric
Sample types
Plasma, Serum
Assay type
Semi-quantitative
Assay Platform
Pre-coated microplate (12 x 8 well strips)

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Storage information
-80°C

Notes

COVID-19 N-Protein Human IgA ELISA Kit (ab276183) is an in vitro indirect ELISA for the semi-quantitative measurement of human IgA antibody against SARS-CoV-2 N protein in human serum.

Standard 96-well plates (12 strips with 8 wells/strip) are coated with the SARSCoV-2 N protein, which combines with the corresponding antibody present in a sample. When a secondary anti-human Antibody-HRP is added, a complex of Antibody-HRP human IgA antibody virus N antigen forms on the microplate. A TMB substrate is added and a blue color is generated. The depth of color is relative to the amount of the anti-SARS-CoV-2 IgA antibody present. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.

The Positive Control is from an inactivated serum sample which contains SARS-COV-2 N protein human IgA antibody. We do not know the exact amount of SARS-COV-2 N protein human IgA antibody in the Positive Control sample. The Positive Control can be used as calibration curve for interpretation purposes in different assays.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

COVID-19 N-Protein also known as the nucleocapsid protein of SARS-CoV-2 plays a fundamental role in the virus's life cycle. Mechanically it binds to the viral RNA genome forming a ribonucleoprotein complex that is critical for viral replication. N-Protein's approximate molecular mass is around 46 kDa. It is expressed in the cytoplasm of infected cells and is highly abundant making it an important target for diagnostic assays like the COVID-19 ELISA test.

Biological function summary

The N-Protein functions as a structural component of the coronavirus. It facilitates the encapsidation of the viral genome and forms part of the viral replication-transcription complexes. The N-Protein interacts with other viral proteins such as the membrane (M) protein indicating its involvement in viral assembly and release. It influences the host cell's response to infection by modulating various cellular processes.

Pathways

The COVID-19 N-Protein participates in the replication and transcription pathway of SARS-CoV-2. It engages with RNA polymerase and NSP3 to support efficient viral RNA synthesis. This protein is related to the structural pathway of viral particles where it ensures the stability and packaging of the viral genome alongside proteins like the S (spike) and E (envelope) proteins.

Associated diseases and disorders

The COVID-19 N-Protein is closely associated with the pathogenesis of COVID-19. It triggers an immune response making it a target for antibody detection in serological assays such as the COVID-19 ELISA kit. The N-Protein's interaction with host cell components may influence disease severity by affecting interferon pathways linked to other structural proteins like the S-protein. Understanding these interactions helps in developing therapeutic strategies against COVID-19.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

0 product images

    Downloads

    Product protocols

    For this product, it's our understanding that no specific protocols are required. You can:

    Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

    For licensing inquiries, please contact partnerships@abcam.com